Paper Details
- Home
- Paper Details
An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.
Author: MortadaSana Mohamed, MotawaaAdel Mohamed, SallamMarwa Ahmed
Original Abstract of the Article :
Diflunisal is a NSAID used in acute and long term management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and symptoms of primary dysmenorrhea. However, its oral use is associated with side effects such as peptic ulceration, dyspepsia, gastrointestinal disturbances a...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.3109/03639045.2013.850711
データ提供:米国国立医学図書館(NLM)
Delivering Diflunisal: A Transdermal Solution for Pain Relief?
The search for more effective and less invasive ways to deliver pain relief medications is ongoing. This research explores the potential of transdermal delivery systems for diflunisal, a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and dysmenorrhea. The authors investigated the use of lecithin organogels (LO) as a transdermal delivery system for diflunisal and compared its human skin penetration ability to an optimized microemulsion-based hydrogel.
Transdermal Delivery: A Promising Path
The research indicates that lecithin organogels (LO) are a potential carrier for transdermal delivery of diflunisal. The LO delivered a higher total drug amount through the skin compared to the hydrogel, suggesting its potential as a more efficient transdermal delivery system. The authors also explored the effect of lecithin composition on skin permeability enhancement, finding that lecithin with a higher amount of phosphatidyl ethanolamine could provide better transdermal delivery.
Navigating the Sands of Pain Management
This research provides valuable insights into the potential of transdermal delivery systems for diflunisal. The findings suggest that LO could be a viable alternative to oral administration, offering a more convenient and potentially safer method for delivering this NSAID. It's like navigating a vast desert - finding a new oasis of pain relief through a different route.
Dr. Camel's Conclusion
This research explores the potential of transdermal delivery systems for diflunisal, a pain-relieving NSAID. The research suggests that lecithin organogels (LO) could offer a more efficient and potentially safer alternative to oral administration, leading to a more convenient experience for patients seeking relief from pain and inflammation. It's like finding a new oasis in a vast desert, offering a more comfortable and effective way to quench the thirst for pain relief.
Date :
- Date Completed 2015-08-24
- Date Revised 2017-11-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.